Misha Siddiqui[1,*]
Azam Hamidinekoo[3]
Jennifer Y Tan[4]
Renata Leke[5]
Bader Zarrouki[5]
Nick Trahearn[6]
Yeman Brhane Hagos[4]
Chirine Sakr[6]
Andrea Lampis[6]
Christopher Bagnall[2]
Giovanni Pellegrini[7]
Simon P Castillo[8]
Benjamin Challis[9]
Yinyin Yuan[8]
Marco Bezzi[1]
Stephanie Ling[2]

[*] Correspondence: misha.siddiqui@astrazeneca.com
[1]{Molecular Pathology, The Institute of Cancer Research (ICR), London, UK}
[2]{Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R\&D, AstraZeneca, Cambridge, UK}
[3]{Image Analysis and Platform, Pathology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals
R\&D, AstraZeneca, Cambridge, UK}
[4]{Imaging and Data Analytics, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals
R\&D, AstraZeneca, Cambridge, UK}
[5]{Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R\&D, AstraZeneca, Gothenburg, Sweden}
[6]{Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK}
[7]{ Aptuit (Verona) Srl, an Evotec Company, Campus Levi Montalcini,
Verona, Italy Aptuit (Verona) Srl, an Evotec Company, Campus Levi Montalcini,
Verona, Italy}
[8]{Department of Translational Molecular Pathology & Institute for Data Science in Oncology, The University of Texas MD Anderson Cancer Center, Texas 77030, USA}
[9]{Translational Science \& Experimental Medicine Research and Early Development, Cardiovascular , Renal \& Metabolism, BioPharmaceuticals R\&D, AstraZeneca, Cambridge, UK}
